It was demonstrated that the aberrant expression of CLDN2, CLDN4, CLDN5, CLDN7, and CLDN23 are associated with the clinical value in colorectal tumors (Cherradi et al., 2019). Here, CLDN23 is linked to colorectal neoplasm.